Combining a Fusion Inhibitory Peptide Targeting the MERS-CoV S2 Protein HR1 Domain and a Neutralizing Antibody Specific for the S1 Protein Receptor-Binding Domain (RBD) Showed Potent Synergism against Pseudotyped MERS-CoV with or without Mutations in RBD

DOI: 10.3390/v11010031

Keywords: MERS-CoV, RBD, mutation, peptide, neutralizing antibody, combination

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text